Expertise in
4
conditions

Yuzaburo Inoue

Chiba, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Chiba, JP 

Overview

Yuzaburo Inoue practices practicing medicine in Chiba, Japan.

Inoue is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Blau Syndrome, Mosaic Trisomy 9, Juvenile Idiopathic Arthritis (JIA), and Kimura Disease.

They are actively involved in clinical research, co-authoring 66 peer reviewed articles and participating in 2 clinical trials.

Locations

Chiba, Japan
Other Locations
Togane, Japan
Chuo, 2608670, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

66 Total Publications

Association between ongoing food avoidance related to childhood-onset food allergy and economic/social independence in young adults: A general population-based web survey in Japan.
Association between ongoing food avoidance related to childhood-onset food allergy and economic/social independence in young adults: A general population-based web survey in Japan.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: March 10, 2026

Frequently Asked Questions about Yuzaburo Inoue

Is Yuzaburo Inoue a top-rated expert for Blau Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Yuzaburo Inoue is classified as an Advanced expert for Blau Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yuzaburo Inoue participate in research or clinical trials?

Yes. Yuzaburo Inoue has published 66 articles and abstracts on conditions like Blau Syndrome. You can view a list of Yuzaburo Inoue's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Inoue's expertise for a condition
ConditionClose
      View All 30 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile